John Kane, MD
John Kane, MD
The Zucker Hillside Hospital
- Consultant: Alkermes; Bristol-Myers Squibb; Eli Lilly and Company; EnVivo Pharmaceuticals; Forest Laboratories, Inc.; Genentech, Inc.; Hoffmann-La Roche Inc.; Intra-Cellular Therapies, Inc.; Janssen-Cilag Pty Limited; Johnson & Johnson Services, Inc.; Lundbeck Inc; Otsuka America Pharmaceutical, Inc.; Reviva; Therapeutics
- Research Support: Bristol-Myers Squibb; Genentech, Inc.
- Speakers Bureau: Janssen-Cilag Pty Limited; Otsuka America Pharmaceutical, Inc.
- Stock or Equity: Medavante Inc